Arefa Yesmin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arefa Yesmin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Afroza Kutubi
Department of Obstetrics & Gynaecology, Sir Salimullah Medical College Mitford Hospital, Dhaka, Bangladesh
1 shared publication- Farhana Mahfuz
Department of Obstetrics and Gynaecology, 250 Bed General Hospital, Barguna, Bangladesh
1 shared publication - Mohammad Azmain Iktidar
North South University
1 shared publication Moshfiqur Rahman
Department of ENT & Head Neck Surgery, Sir Salimullah Medical College Mitford Hospital, Dhaka, Bangladesh
1 shared publicationMowmita Zaman Khan
Department of Obstetrics and Gynaecology, 250 Bed Sadar Hospital, Moulvibazar, Bangladesh
1 shared publicationMst. Irin Nahar
Department of Obstetrics and Gynaecology, Rajshahi Medical College Hospital, Rajshahi, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (9) , 5678-5684
Efficacy of the swede score in optimizing triage of visual inspection with acetic acid positive women: cross-sectional evidence from Bangladesh
Background: Conventional screening methods for cervical cancer, such as visual inspection with acetic acid (VIA), have limited specificity. The Swede score, a structured colposcopic scoring system, may improve detection and triage of cervical intraepithelial neoplasia (CIN) in VIA-positive women. Methods: This cross-sectional study was conducted in the Department of Obstetrics and Gynecology at a tertiary-level hospital in Bangladesh from October 2023 to July 2024. A total of 60 VIA-positive women meeting the selection criteria were consecutively enrolled after providing informed consent. Socio-demographic information and detailed medical history were recorded. All participants underwent colposcopic assessment using the Swede score, followed by colposcopy-guided biopsy. Data were analyzed using Stata (version 17). Results: The mean age was 41.7 ± 8.1 years, with 41.7% aged 40–49 and 48.3% having below-secondary education. Chronic cervicitis was found in 50%, while 30% had CIN1 and 18.3% had CIN2+. The mean Swede score was 5.3 ± 2.0. Notably, 96.6% of women with abnormal histopathology had Swede scores of 5–10, while 61.3% of those with normal histology scored 0–4. A Swede score cut-off of 6 demonstrated high sensitivity (82.8%) and specificity (96.8%) for CIN1+ (PPV 96.0%, NPV 85.7%). For CIN2+, a cut-off of 7 achieved perfect sensitivity (100%) and high specificity (85.7%), with an NPV of 100%. Multivariate analysis showed that each unit increase in Swede score increased the risk of CIN by 39-fold (AOR: 39.14, 95% CI: 2.33–658.33). Conclusion: The Swede score is a reliable tool for detecting CIN among VIA-positive women, supporting its use for targeted biopsies and “see-and-treat” strategies in low-resource settings.
- 21 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (9) , 5678-5684
Open AccessEfficacy of the swede score in optimizing triage of visual inspection with acetic acid positive women: cross-sectional evidence from Bangladesh
Background: Conventional screening methods for cervical cancer, such as visual inspection with acetic acid (VIA), have limited specificity. The Swede score, a structured colposcopic scoring system, may improve detection and triage of cervical intraepithelial neoplasia (CIN) in VIA-positive women. Methods: This cross-sectional study was conducted in the Department of Obstetrics and Gynecology at a tertiary-level hospital in Bangladesh from October 2023 to July 2024. A total of 60 VIA-positive women meeting the selection criteria were consecutively enrolled after providing informed consent. Socio-demographic information and detailed medical history were recorded. All participants underwent colposcopic assessment using the Swede score, followed by colposcopy-guided biopsy. Data were analyzed using Stata (version 17). Results: The mean age was 41.7 ± 8.1 years, with 41.7% aged 40–49 and 48.3% having below-secondary education. Chronic cervicitis was found in 50%, while 30% had CIN1 and 18.3% had CIN2+. The mean Swede score was 5.3 ± 2.0. Notably, 96.6% of women with abnormal histopathology had Swede scores of 5–10, while 61.3% of those with normal histology scored 0–4. A Swede score cut-off of 6 demonstrated high sensitivity (82.8%) and specificity (96.8%) for CIN1+ (PPV 96.0%, NPV 85.7%). For CIN2+, a cut-off of 7 achieved perfect sensitivity (100%) and high specificity (85.7%), with an NPV of 100%. Multivariate analysis showed that each unit increase in Swede score increased the risk of CIN by 39-fold (AOR: 39.14, 95% CI: 2.33–658.33). Conclusion: The Swede score is a reliable tool for detecting CIN among VIA-positive women, supporting its use for targeted biopsies and “see-and-treat” strategies in low-resource settings.